Summary
The novel alkylxanthine, denbufylline [1,3-di-n-butyl-7-(2-oxopropyl)-xanthine] has been examined, in vitro, for effects on the viscosity of rat whole blood and on the filterability of rat blood cell suspensions. For comparison, pentoxifylline was also examined for theological activity. Denbufylline reduced the viscosity of whole blood at all shear rates utilised, up to 128.5 s−1. The effect was, however, more pronounced at a low (0.7 s−1) than at a high (94.5 s−1) shear rate indicating that the compound reduces blood cell aggregation and increases blood cell deformability. Denbufylline also increased the filterability of blood cell suspensions. This is further evidence that the compound increases the deformability of blood cells. Denbufylline elevated the filterability of both pure erythrocyte and mixed erythrocyte/leucocyte suspensions, the effect being greatest with the latter. This suggests that denbufylline may influence the deformability of both red and white blood cells. However, the effect on white blood cells, under the experimental conditions employed, is apparently more marked. Pentoxifylline also reduced the viscosity of rat whole blood and increased the filterability of rat blood cell suspensions. However, denbufylline was 10–100-fold more potent in these tests than pentoxifylline.
Similar content being viewed by others
References
Angelkort B, Maurin N, Boateng K (1979) Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease. Commun Med Res Opin 6:255–258
Angelkort B, Kiesewetter H (1981) Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic occlusive arterial disease. Scand J Clin Invest 41 (Suppl 156): 185–188
Angelkort B, Spark P, Habbada A, Mähder M (1985) Blood flow properties and walking performance in chronic arterial occlusive disease. Angiology 36:285–292
Angersbach D, Ochlich P (1984) The effect of 7-(2-oxopropyl)-1,3-di-n-butyl-xanthine (BRL 30892) on ischaemic skeletal muscle pO2, pH and contractility in cats and rats. Arzneimittelforsch 34:1274–1278
Aviado DM, Porter JM (1984) Pentoxifylline: a new drug for the treatment of intermittent claudication. Pharmacotherapy 4:297–307
Bucherer C, Lacombe C, Lelievre JC (1984) Comparison between two methods, viscometry and filtration, for red blood cell deformability evaluation. Effect of pentoxifylline. Clin Haemorheol 4:387–393
Dettelbach HR, Aviado DM (1985) Clinical pharmacology of pentoxifylline with special reference to its hemorheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25:8–26
Dintenfass L (1981) Clinical applications of hemorheology. In: Gross DA, Hwang NHC (eds) The rheology of blood, blood vessels and associated tissues. Sijthoff and Noordhoff, Alphen aan den Ryn, pp 22–50
Dormandy J, Hoare E, Postlethwaite J (1976) Blood viscosity of patients with intermittent claudication − concept of “rheological claudication”. Biorheology 13:161–164
Dormandy JA (1981) Drug modification of erythrocyte deformability. In: Lowe GDO, Berbenel JE, Forbes CD (eds) Clinical aspects of blood viscosity and cell deformability. Springer, Berlin Heidelberg New York, pp 251–256
Dormandy J, Ernst E, Flute P (1981a) Increase in red cell filterability after incubation with oxpentifylline. Curr Med Res Opin 7:520–522
Dormandy JA, Yates CJP, Berent GA (1981b) Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects. Angiology 32:236–242
Dormandy JA (1983) Red cell deformability. Eur J Neurol 22 (Suppl 1):23–29
Ehrly AM (1975) Beeinflussung der Verformbarkeit der Erythrozyten durch Pentoxifyllin. Med Welt 51:2300–2301
Ehrly AM (1981) New pathophysiological concept of ischaemic diseases: Microcirculatory blood maldistribution (MBM). Biblthca Anat 20:456–460
Ehrly AM, Landgraf H (1981) Red blood cell filterability and occlusive arterial disease. Scand J Clin Lab Invest 41 (Suppl 156):181–184
Ernst E, Matrai A, Weihmayr T, Bushe B, Paulsen F (1985) Behandlung der arteriellen Verschlußkrankheiten Stadium II. Manch Med Wochenschr 127:917–919
Forconi S (1983) Clinical relevance of filtration tests. In: Dormandy J (ed) Red cell deformability and filterability. Martinus Nijhoff, Boston, pp 198–203
Hess H, Franke I, Jauch M (1973) Medikamentöse Verbesserung der Fließeigenschaften des Blutes. Fortschr Med 91:743–748
Hinze H-J (1972) Zur Pharmakokinetik von 3,7-Dimethyl-1-(5-oxohexyl)-xanthine (BRL 191) am Menschen. Arzneimittelforsch 22:1492–1495
Isogai Y, Mochizuki K, Ashikaga M (1981) A new method of measuring red cell deformability and the effects of pentoxifylline. Curr Med Res Opin 7:352–358
Kenny MW, Meakin M, Stuart J (1983) Methods for removal of leucocytes and platelets prior to study of erythrocyte deformability. Clin Haemorheol 3:191–200
Leonhardt H, Grigoleit H-G, Reinhardt I (1977) Veründerung und Zusammenhänge der Erythrozytenflexibilität und Vollblutviskosität normoosmolarer und hyperosmolarer Erythrozyten Suspensionen unter Einwirkung von 2,7-Dimethyl-1-(5-oxohexyl)-xanthin. Vasa 6:316–320
Leonhardt H, Grigoleit H-G (1977) Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Naunyn-Schmiedeberg's Arch Pharmacol 299:197–200
Matrai A, Ernst E (1985) Pentoxifylline improves white cell rheology in claudicants. Clin Haemorheol 5:483–491
Mailer R (1981) Hemorheology and peripheral vascular disease a new therapeutic approach. J Med 12:209–236
Nicholson CD, Wilke R (1986) The apparent tissue specificity of some alkylxanthines as phoshodiesterase inhibitors. Naunyn-Schmiedeberg's Arch Pharmacol 332:R33
Nishio T, Toshima Y, Matsuno Y (1982) Effects of pentoxifylline on cell shape ATP content and erythrocyte deformability in rabbit erythrocytes under hyperosmolar conditions. Int J Biochem 14:915–920
Ott EO, Lechner H, Aranibar A (1974) High blood viscosity syndrome in cerebral infarction. Stroke 5:330–333
Reid HL, Dormandy JA, Barnes AJ, Lock PJ, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet I:666–668
Rieger H (1981) Clinical application of hemodilution, therapy and practise. In: Gross DR, Hwang NHC (eds) The rheology of blood, blood vessels and associated tissues. Sijthoff and Noordhoff, Alphen an den Ryn, pp 73–92
Schmalzer EA, Chien S (1984) Filterability of subpopulations of leukocytes: effect of pentoxifylline. Blood 64:542–546
Schmid-Schönbein H (1976) Microrheology of erythrocytes, blood viscosity and the distribution of blood flow in the microcirculation. In: Guyton AC, Cowley AW (eds) Rev Physiol, vol 9. University Park Press, Baltimore, pp 1–61
Schubotz R, Mahlfellner O (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphate fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4:609–617
Seiffge D (1980) Methods for the investigation of drug influence on aggregation and deformability of red blood cells (RBC). In: Stoltz JF, Drouin P (eds) Haemorheology and disease. Doin, Paris, pp 657–663
Spinelli FR, Meier CD (1974) Measurements of blood viscosity. Biorheol 11:301–306
Störmer B, Horsch R, Kleinschmidt F, Loose D, Brüster H, Kremer K (1974) Blood viscosity in patients with peripheral vascular diseases in the area of low shear rates. J Cardiovasc Surg 15:577–584
Teitel P, Mussler K (1981) Mikrocomputerunterstützte Analyse des Fließverhaltens von Erythrozyten. In: Mikrozirkulation und arterielle Verschlußkrankheiten. Karger, Basel, pp 63–76
Author information
Authors and Affiliations
Additional information
Part of this work was presented at the 1985 Aachen Joint Meeting of the Belgian, Dutch and German Pharmacological and Toxicological Societies
Send offprint requests to C. D. Nicholson at the above address
Rights and permissions
About this article
Cite this article
Jukna, J.J., Nicholson, C.D. The effect of denbufylline on the viscosity of rat whole blood and on the deformability (filterability) of rat blood cell suspensions. Naunyn-Schmiedeberg's Arch Pharmacol 335, 445–448 (1987). https://doi.org/10.1007/BF00165561
Issue Date:
DOI: https://doi.org/10.1007/BF00165561